220 related articles for article (PubMed ID: 2481670)
1. The use of endocrine therapy.
Pritchard KI; Sutherland DJ
Hematol Oncol Clin North Am; 1989 Dec; 3(4):765-805. PubMed ID: 2481670
[TBL] [Abstract][Full Text] [Related]
2. Management of breast cancer.
Cohen IA; Keller JH; Abate MA
Clin Pharm; 1982; 1(6):515-29. PubMed ID: 6192963
[TBL] [Abstract][Full Text] [Related]
3. Cancer of the breast. Endocrine and hormonal therapy.
Kardinal CG; Donegan WL
Major Probl Clin Surg; 1979; 5():361-404. PubMed ID: 379452
[TBL] [Abstract][Full Text] [Related]
4. Update on endocrine therapy for breast cancer.
Buzdar AU; Hortobagyi G
Clin Cancer Res; 1998 Mar; 4(3):527-34. PubMed ID: 9533518
[TBL] [Abstract][Full Text] [Related]
5. [Hormonal treatment of breast tumor].
Garcia Giralt E; Omodei Zorini C
Clin Ter; 1990 Feb; 132(4):217-27. PubMed ID: 2140308
[No Abstract] [Full Text] [Related]
6. Endocrine therapy of breast and prostate cancer.
Manni A
Endocrinol Metab Clin North Am; 1989 Jun; 18(2):569-92. PubMed ID: 2663486
[TBL] [Abstract][Full Text] [Related]
7. What role for concurrent chemohormonal therapy in breast cancer?
Sheth SP; Allegra JC
Oncology (Williston Park); 1987 Oct; 1(8):19-27. PubMed ID: 3079489
[TBL] [Abstract][Full Text] [Related]
8. [Endocrine therapy of breast cancer. Status and perspectives].
Jänicke F
Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):677-86. PubMed ID: 3069556
[TBL] [Abstract][Full Text] [Related]
9. Fundamental research leading to improved endocrine therapy for breast cancer.
Miller WR
J Steroid Biochem; 1987; 27(1-3):477-85. PubMed ID: 3320538
[TBL] [Abstract][Full Text] [Related]
10. Molecular Action and Clinical Relevance of Aromatase Inhibitors.
Murphy MJ
Oncologist; 1998; 3(2):129-130. PubMed ID: 10388095
[TBL] [Abstract][Full Text] [Related]
11. Combined ovarian ablation and aromatase inhibition as first-line therapy for hormone receptor-positive metastatic breast cancer in premenopausal women: report of three cases.
El-Saghir NS; El-Hajj II; Makarem JA; Otrock ZK
Anticancer Drugs; 2006 Sep; 17(8):999-1002. PubMed ID: 16940812
[TBL] [Abstract][Full Text] [Related]
12. [The use of GnRH analogues in early and advanced breast carcinomas].
Ségura C; Avenin D; Gligorov J; Selle F; Estéso A; Beerblock K; Emile G; Do Huyen N; Lotz JP
Gynecol Obstet Fertil; 2005 Nov; 33(11):914-9. PubMed ID: 16246613
[TBL] [Abstract][Full Text] [Related]
13. [Present status of endocrine therapy of breast cancer: a surgeon's view].
Nomura Y
Gan To Kagaku Ryoho; 1984 May; 11(5):981-8. PubMed ID: 6426405
[TBL] [Abstract][Full Text] [Related]
14. Endocrine therapy in metastatic breast cancer.
Kimmick GG; Muss HB
Cancer Treat Res; 1998; 94():231-54. PubMed ID: 9587691
[TBL] [Abstract][Full Text] [Related]
15. Ovarian ablation as treatment for young women with breast cancer.
Davidson NE
J Natl Cancer Inst Monogr; 1994; (16):95-9. PubMed ID: 7528032
[TBL] [Abstract][Full Text] [Related]
16. Aromatase inhibitors: rationale for use following antiestrogen therapy.
Yue W; Santen RJ
Semin Oncol; 1996 Aug; 23(4 Suppl 9):21-7. PubMed ID: 8824461
[TBL] [Abstract][Full Text] [Related]
17. Progression of endocrine therapies for breast cancer: where are we headed?
Arnedos M; Smith I
Expert Rev Anticancer Ther; 2007 Nov; 7(11):1651-64. PubMed ID: 18020931
[TBL] [Abstract][Full Text] [Related]
18. [Developments in endocrine therapy for breast cancer].
Matsui A; Ikeda T; Jinno H; Tajima G; Hohjou T; Tokura H; Mitsui Y; Asaga S; Muto T; Kitajima M
Gan To Kagaku Ryoho; 2002 Jul; 29(7):1138-45. PubMed ID: 12145993
[TBL] [Abstract][Full Text] [Related]
19. Endocrine therapy for advanced breast cancer: a review.
Muss HB
Breast Cancer Res Treat; 1992; 21(1):15-26. PubMed ID: 1382723
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic manipulation of steroid hormones. Adjunctive therapies in cancer of the breast.
Manni A
Endocrinol Metab Clin North Am; 1991 Dec; 20(4):825-44. PubMed ID: 1778179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
